LPS-induced renal inflammation is prevented by (−)‐epicatechin in rats

Redox Biology

Volumn 11, Issue , 2017, Pages 342-349

  Prince, Paula Denise ^a   Fischerman, Laura ^a   Toblli, Jorge E ^b   Fraga, Cesar G ^a,c   Galleano, Monica ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL ALEMÁN   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endotoxemia; Flavonoids; Reactive oxygen species; Renopathies; Toll like receptors

Indexed keywords

CREATININE; EPICATECHIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALONALDEHYDE; OXIDOREDUCTASE; P47PHOX PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CATECHIN; CYBB PROTEIN, RAT; NEUTROPHIL CYTOSOLIC FACTOR 1; NOS2 PROTEIN, RAT; NOX4 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TLR4 PROTEIN, RAT; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME ACTIVATION; INFLAMMATION; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY INJURY; LIPID PEROXIDATION; MALE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CATECHIN; CREATININE; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; KIDNEY; LIPOPOLYSACCHARIDES; MALE; NADPH OXIDASE 2; NADPH OXIDASE 4; NADPH OXIDASES; NEPHRITIS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UREA;

EID: 85007107358     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.12.023     Document Type: Article

References (46)

1. [1] Basciano, H., Federico, L., Adeli, K., Fructose, insulin resistance, and metabolic dyslipidemia. Nutr. Metab., 2, 2005, 5, 10.1186/1743-7075-2-5.
2. [2] Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105 (2014), 141–150, 10.1016/j.diabres.2014.04.006.
3. [3] Lastra, G., Manrique, C., McFarlane, S.I., Sowers, J.R., Cardiometabolic syndrome and chronic kidney disease. Curr. Diabetes Rep. 6 (2006), 207–212.
4. [4] Schrier, R.W., Wang, W., Poole, B., Mitra, A., Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest. 114 (2004), 5–14, 10.1172/JCI22353.
5. [5] Lawrence, T., The nuclear factor NF-κB pathway in. Inflamm. Cold Spring Harb. Perspect. Biol., 1, 2009, 10.1101/cshperspect.a001651.
6. [6] Oeckinghaus, A., Ghosh, S., The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol., 1, 2009, a000034, 10.1101/cshperspect.a000034.
7. [7] Hayden, M.S., West, A.P., Ghosh, S., NF-kappaB and the immune response. Oncogene 25 (2006), 6758–6780, 10.1038/sj.onc.1209943.
8. [8] Fan, J., Frey, R.S., Malik, A.B., TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 112 (2003), 1234–1243, 10.1172/JCI18696.
9. [9] Qin, L., Li, G., Qian, X., Liu, Y., Wu, X., Liu, B., Hong, J.-S., Block, M.L., Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52 (2005), 78–84, 10.1002/glia.20225.
10. [10] Park, H.S., Jung, H.Y., Park, E.Y., Kim, J., Lee, W.J., Bae, Y.S., Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. Baltim. Md 1950 173 (2004), 3589–3593.
11. [11] Fraga, C.G., Plant polyphenols: how totranslate their in vitro antioxidant actions to in vivo conditions. IUBMB Life, 59, 2007, 308–315, 10.1080/15216540701230529.
12. [12] Fraga, C.G., Litterio, M.C., Prince, P.D., Calabró, V., Piotrkowski, B., Galleano, M., Cocoa flavanols: effects on vascular nitric oxide and blood pressure. J. Clin. Biochem. Nutr. 48 (2011), 63–67, 10.3164/jcbn.11-010FR.
13. [13] Mink, P.J., Scrafford, C.G., Barraj, L.M., Harnack, L., Hong, C.-P., Nettleton, J.A., Jacobs, D.R., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 85 (2007), 895–909.
14. [14] Hooper, L., Kroon, P.A., Rimm, E.B., Cohn, J.S., Harvey, I., Le Cornu, K.A., Ryder, J.J., Hall, W.L., Cassidy, A., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88 (2008), 38–50.
15. [15] Galleano, M., Calabro, V., Prince, P.D., Litterio, M.C., Piotrkowski, B., Vazquez-Prieto, M.A., Miatello, R.M., Oteiza, P.I., Fraga, C.G., Flavonoids and metabolic syndrome. Ann. N. Y. Acad. Sci. 1259 (2012), 87–94, 10.1111/j.1749-6632.2012.06511.x.
16. [16] Mackenzie, G.G., Oteiza, P.I., Modulation of transcription factor NF-kappaB in Hodgkin's lymphoma cell lines: effect of (-)-epicatechin. Free Radic. Res. 40 (2006), 1086–1094, 10.1080/10715760600788396.
17. [17] Vazquez-Prieto, M.A., Bettaieb, A., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 527 (2012), 113–118, 10.1016/j.abb.2012.02.019.
18. [18] Bettaieb, A., Vazquez Prieto, M.A., Rodriguez Lanzi, C., Miatello, R.M., Haj, F.G., Fraga, C.G., Oteiza, P.I., (-)-Epicatechin mitigates high-fructose-associated insulin resistance by modulating redox signaling and endoplasmic reticulum stress. Free Radic. Biol. Med. 72 (2014), 247–256, 10.1016/j.freeradbiomed.2014.04.011.
19. [19] Morrison, M., van der Heijden, R., Heeringa, P., Kaijzel, E., Verschuren, L., Blomhoff, R., Kooistra, T., Kleemann, R., Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis 233 (2014), 149–156, 10.1016/j.atherosclerosis.2013.12.027.
20. [20] Giani, J.F., Muñoz, M.C., Pons, R.A., Cao, G., Toblli, J.E., Turyn, D., Dominici, F.P., Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Ren. Physiol. 300 (2011), F272–F282, 10.1152/ajprenal.00278.2010.
21. [21] Aimo, L., Mackenzie, G.G., Keenan, A.H., Oteiza, P.I., Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-κB and NFAT in fetal brain. J. Nutr. Biochem. 21 (2010), 1069–1075, 10.1016/j.jnutbio.2009.09.003.
22. [22] Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
23. [23] Li, J.-M., Wheatcroft, S., Fan, L.M., Kearney, M.T., Shah, A.M., Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation. Circulation 109 (2004), 1307–1313, 10.1161/01.CIR.0000118463.23388.B9.
24. [24] Litterio, M.C., Jaggers, G., Celep, G. Sagdicoglu, Adamo, A.M., Costa, M.A., Oteiza, P.I., Fraga, C.G., Galleano, M., Blood pressure-lowering effect of dietary (-)-epicatechin administration in L-NAME-treated rats is associated with restored nitric oxide levels. Free Radic. Biol. Med. 53 (2012), 1894–1902, 10.1016/j.freeradbiomed.2012.08.585.
25. [25] Yao, J., Pan, D., Zhao, Y., Zhao, L., Sun, J., Wang, Y., You, Q.-D., Xi, T., Guo, Q.-L., Lu, N., Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway. Immunology 143 (2014), 241–257, 10.1111/imm.12305.
26. [26] Cheng, P.-Y., Lee, Y.-M., Wu, Y.-S., Chang, T.-W., Jin, J.-S., Yen, M.-H., Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem. Pharmacol. 73 (2007), 793–804, 10.1016/j.bcp.2006.11.025.
27. [27] Radnai, B., Tucsek, Z., Bognar, Z., Antus, C., Mark, L., Berente, Z., Gallyas, F., Sumegi, B., Veres, B., Ferulaldehyde, a water-soluble degradation product of polyphenols, inhibits the lipopolysaccharide-induced inflammatory response in mice. J. Nutr. 139 (2009), 291–297, 10.3945/jn.108.097386.
28. [28] Pallarès, V., Fernández-Iglesias, A., Cedó, L., Castell-Auví, A., Pinent, M., Ardévol, A., Salvadó, M.J., Garcia-Vallvé, S., Blay, M., Grape seed procyanidin extract reduces the endotoxic effects induced by lipopolysaccharide in rats. Free Radic. Biol. Med. 60 (2013), 107–114, 10.1016/j.freeradbiomed.2013.02.007.
29. [29] Nair, A.R., Masson, G.S., Ebenezer, P.J., Piero, F. Del, Francis, J., Role of TLR4 in lipopolysaccharide-induced acute kidney injury: protection by blueberry. Free Radic. Biol. Med. 71 (2014), 16–25, 10.1016/j.freeradbiomed.2014.03.012.
30. [30] Bettaieb, A., Cremonini, E., Kang, H., Kang, J., Haj, F.G., Oteiza, P.I., Anti-inflammatory actions of (-)-epicatechin in the adipose tissue of obese mice. Int. J. Biochem. Cell Biol., 2016, 10.1016/j.biocel.2016.08.044.
31. [31] Prince, P.D., Lanzi, C.R., Toblli, J.E., Elesgaray, R., Oteiza, P.I., Fraga, C.G., Galleano, M., Dietary (-)-epicatechin mitigates oxidative stress, NO metabolism alterations, and inflammation in renal cortex from fructose-fed rats. Free Radic. Biol. Med. 90 (2016), 35–46, 10.1016/j.freeradbiomed.2015.11.009.
32. [32] El-Achkar, T.M., Huang, X., Plotkin, Z., Sandoval, R.M., Rhodes, G.J., Dagher, P.C., Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney. Am. J. Physiol. Ren. Physiol. 290 (2006), F1034–F1043, 10.1152/ajprenal.00414.2005.
33. [33] Wang, W., Deng, M., Liu, X., Ai, W., Tang, Q., Hu, J., TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 34 (2011), 509–518, 10.1007/s10753-010-9258-4.
34. [34] Janardhan, K.S., McIsaac, M., Fowlie, J., Shrivastav, A., Caldwell, S., Sharma, R.K., Singh, B., Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol. Histopathol. 21 (2006), 687–696.
35. [35] Bao, S., Cao, Y., Zhou, H., Sun, X., Shan, Z., Teng, W., Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes. J. Agric. Food Chem. 63 (2015), 2811–2819, 10.1021/jf505531w.
36. [36] Delehanty, J.B., Johnson, B.J., Hickey, T.E., Pons, T., Ligler, F.S., Binding and neutralization of lipopolysaccharides by plant proanthocyanidins. J. Nat. Prod. 70 (2007), 1718–1724, 10.1021/np0703601.
37. [37] Kaneko, M., Takimoto, H., Sugiyama, T., Seki, Y., Kawaguchi, K., Kumazawa, Y., Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors. Immunopharmacol. Immunotoxicol. 30 (2008), 867–882, 10.1080/08923970802135690.
38. [38] Park, S.-J., Youn, H.-S., Suppression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry 71 (2010), 1736–1740, 10.1016/j.phytochem.2010.07.008.
39. [39] Steffen, Y., Schewe, T., Sies, H., (–)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun. 359 (2007), 828–833, 10.1016/j.bbrc.2007.05.200.
40. [40] Steffen, Y., Gruber, C., Schewe, T., Sies, H., Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 469 (2008), 209–219, 10.1016/j.abb.2007.10.012.
41. [41] Ottaviani, J.I., Momma, T.Y., Kuhnle, G.K., Keen, C.L., Schroeter, H., Structurally related (-)-epicatechin metabolites in humans: assessment using de novo chemically synthesized authentic standards. Free Radic. Biol. Med. 52 (2012), 1403–1412, 10.1016/j.freeradbiomed.2011.12.010.
42. [42] Actis-Goretta, L., Lévèques, A., Giuffrida, F., Romanov-Michailidis, F., Viton, F., Barron, D., Duenas-Paton, M., Gonzalez-Manzano, S., Santos-Buelga, C., Williamson, G., Dionisi, F., Elucidation of (-)-epicatechin metabolites after ingestion of chocolate by healthy humans. Free Radic. Biol. Med. 53 (2012), 787–795, 10.1016/j.freeradbiomed.2012.05.023.
43. [43] Galleano, M., Verstraeten, S.V., Oteiza, P.I., Fraga, C.G., Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch. Biochem. Biophys. 501 (2010), 23–30, 10.1016/j.abb.2010.04.005.
44. [44] Gómez-Guzmán, M., Jiménez, R., Sánchez, M., Zarzuelo, M.J., Galindo, P., Quintela, A.M., López-Sepúlveda, R., Romero, M., Tamargo, J., Vargas, F., Pérez-Vizcaíno, F., Duarte, J., Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic. Biol. Med. 52 (2012), 70–79, 10.1016/j.freeradbiomed.2011.09.015.
45. [45] Gloire, G., Legrand-Poels, S., Piette, J., NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006), 1493–1505, 10.1016/j.bcp.2006.04.011.
46. [46] Fraga, C.G., Oteiza, P.I., Dietary flavonoids: role of (-)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 51 (2011), 813–823, 10.1016/j.freeradbiomed.2011.06.002.